Tag: Zosano Pharma

February 9, 2022 Off

Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of…

March 14, 2019 Off

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results

By BusinessWire

FREMONT, Calif.–(BUSINESS WIRE)–Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage
biopharmaceutical company, today announced financial results for the
fourth quarter and year ended December 31, 2018, as well as recent
bus…